Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma Advanced Research Company (SPARC) has published a public notice in the Financial Express (English and Gujarati editions) dated July 24, 2025, informing shareholders about an addendum to its Annual Report for FY 2024-25. The addendum includes the Management Discussion & Analysis Report, which was reportedly missing from the original Annual Report sent electronically to shareholders. The notice was issued in connection with the 20th Annual General Meeting of the company scheduled for August 18, 2025. The filing is being made under Regulation 30 read with Schedule III and Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine regulatory compliance filing with no material impact on stock price or shareholder value. However, the fact that the MD&A was missing from the original Annual Report and had to be added via an addendum is a minor corporate governance concern, though the company appears to have promptly addressed it.